Can a wearable glucose monitor keep up during heart surgery?

NCT ID NCT07385170

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is checking how well the Dexcom G7, a continuous glucose monitor, works in 100 adults having heart surgery. The device is placed on the arm and tracks blood sugar during and after the operation for up to 10 days. The goal is to see if it gives accurate readings in this setting, which could help doctors manage patients' blood sugar more closely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Dexcom G7 continuous glucose monitoring device

What this could lead to

If successful, this could show that the Dexcom G7 is reliable for managing blood sugar in cardiac surgery patients, potentially improving care.

What could go wrong

This is a small, early-stage accuracy study, not a treatment trial. The device may not perform as well in surgery as in other settings, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Seoul National University Hospital

    RECRUITING

    Seoul, 03080, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••